Cost-Effectiveness Analysis of Pneumococcal Vaccination of Adults and Elderly Persons in Belgium

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.17, Iss.6, 2000-06, pp. : 591-601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Pneumococcal Vaccination for Elderly Individuals in The Netherlands

By Postma M.J.

PharmacoEconomics, Vol. 19, Iss. 2, 2001-01 ,pp. : 215-222

Adis International

Access to resources Recommend Favorite

Implementing an Influenza Vaccination Programme for Adults Aged ≥65 Years in Poland: A Cost-Effectiveness Analysis

By Brydak Lidia

Clinical Drug Investigation, Vol. 32, Iss. 2, 2012-02 ,pp. : 73-85

Adis International

Access to resources Recommend Favorite

A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer

By Graham Donna M. Isaranuwatchai Wanrudee Habbous Steven de Oliveira Claire Liu Geoffrey Siu Lillian L. Hoch Jeffrey S.

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1785-1792

Blackwell Publishing

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation: A BENESCO Markov Cost-Effectiveness Analysis

By Annemans Lieven

Clinical Drug Investigation, Vol. 29, Iss. 10, 2009-10 ,pp. : 655-665

Adis International

Access to resources Recommend Favorite